|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dempke WC, Suto T and Reck M: Targeted
therapies for non-small cell lung cancer. Lung Cancer. 67:257–274.
2010. View Article : Google Scholar
|
|
3
|
Kawachi R, Tsukada H, Nakazato Y, Takei H,
Furuyashiki G, Koshi-ishi Y and Goya T: Early recurrence after
surgical resection in patients with pathological stage I non-small
cell lung cancer. Thorac Cardiovasc Surg. 57:472–475. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ji C, Cao C, Lu S, Kivlin R, Amaral A,
Kouttab N, Yang H, Chu W, Bi Z, Di W and Wan Y: Curcumin attenuates
EGF-induced AQP3 up-regulation and cell migration in human ovarian
cancer cells. Cancer Chemother Pharmacol. 62:857–865. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zou P, Helson L, Maitra A, Stern ST and
McNeil SE: Polymeric curcumin nanoparticle pharmacokinetics and
metabolism in bile duct cannulated rats. Mol Pharm. 10:1977–1987.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sakaue-Sawano A, Kurokawa H, Morimura T,
Hanyu A, Hama H, Osawa H, Kashiwagi S, Fukami K, Miyata T, Miyoshi
H, et al: Visualizing spatiotemporal dynamics of multicellular
cell-cycle progression. Cell. 132:487–498. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen HW, Lee JY, Huang JY, Wang CC, Chen
WJ, Su SF, Huang CW, Ho CC, Chen JJ, Tsai MF, et al: Curcumin
inhibits lung cancer cell invasion and metastasis through the tumor
suppressor HLJ1. Cancer Res. 68:7428–7438. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin SS, Lai KC, Hsu SC, Yang JS, Kuo CL,
Lin JP, Ma YS, Wu CC and Chung JG: Curcumin inhibits the migration
and invasion of human A549 lung cancer cells through the inhibition
of matrix metalloproteinase-2 and -9 and Vascular Endothelial
Growth Factor (VEGF). Cancer Lett. 285:127–133. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang CL, Liu YY, Ma YG, Xue YX, Liu DG,
Ren Y, Liu XB, Li Y and Li Z: Curcumin blocks small cell lung
cancer cells migration, invasion, angiogenesis, cell cycle and
neoplasia through Janus kinase-STAT3 signalling pathway. PLoS One.
7:e379602012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sandur SK, Pandey MK, Sung B, Ahn KS,
Murakami A, Sethi G, Limtrakul P, Badmaev V and Aggarwal BB:
Curcumin, demethoxycurcumin, bisdemethoxycurcumin,
tetrahydrocurcumin and turmerones differentially regulate
anti-inflammatory and anti-proliferative responses through a
ROS-independent mechanism. Carcinogenesis. 28:1765–1773. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yodkeeree S, Chaiwangyen W, Garbisa S and
Limtrakul P: Curcumin, demethoxycurcumin and bisdemethoxycurcumin
differentially inhibit cancer cell invasion through the
down-regulation of MMPs and uPA. J Nutr Biochem. 20:87–95. 2009.
View Article : Google Scholar
|
|
12
|
Ikeda T, Ishii KA, Saito Y, Miura M,
Otagiri A, Kawakami Y, Shimano H, Hara H and Takekoshi K:
Inhibition of autophagy enhances sunitinib-induced cytotoxicity in
rat pheochromocytoma PC12 cells. J Pharmacol Sci. 121:67–73. 2013.
View Article : Google Scholar
|
|
13
|
Lagisetty P, Vilekar P, Sahoo K, Anant S
and Awasthi V: CLEF MA-an anti-proliferative curcuminoid from
structure-activity relationship studies on 3,5-bis (benzylidene)
-4-piperidones. Bioorg Med Chem. 18:6109–6120. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xiao K, Jiang J, Guan C, Dong C, Wang G,
Bai L, Sun J, Hu C and Bai C: Curcumin induces autophagy via
activating the AMPK signaling pathway in lung adenocarcinoma cells.
J Pharmacol Sci. 123:102–109. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Maejima Y, Kyoi S, Zhai P, Liu T, Li H,
Ivessa A, Sciarretta S, Del Re DP, Zablocki DK, Hsu CP, et al: Mst1
inhibits autophagy by promoting the interaction between Beclin1 and
Bcl-2. Nat Med. 19:1478–1488. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Boonrao M, Yodkeeree S, Ampasavate C,
Anuchapreeda S and Limtrakul P: The inhibitory effect of turmeric
curcuminoids on matrix metalloproteinase-3 secretion in human
invasive breast carcinoma cells. Arch Pharm Res. 33:989–998. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Killian PH, Kronski E, Michalik KM,
Barbieri O, Astigiano S, Sommerhoff CP, Pfeffer U, Nerlich AG and
Bachmeier BE: Curcumin inhibits prostate cancer metastasis in vivo
by targeting the inflammatory cytokines CXCL1 and -2.
Carcinogenesis. 33:2507–2519. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Siwak DR, Shishodia S, Aggarwal BB and
Kurzrock R: Curcumin-induced antiproliferative and proapoptotic
effects in melanoma cells are associated with suppression of
IkappaB kinase and nuclear factor kappaB activity and are
independent of the B-Raf/mitogen-activated/extracellular
signal-regulated protein kinase pathway and the Akt pathway.
Cancer. 104:879–890. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin YG, Kunnumakkara AB, Nair A, Merritt
WM, Han LY, Armaiz-Pena GN, Kamat AA, Spannuth WA, Gershenson DM,
Lutgendorf SK, et al: Curcumin inhibits tumor growth and
angiogenesis in ovarian carcinoma by targeting the nuclear
factor-kappaB pathway. Clin Cancer Res. 13:3423–3430. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Glienke W, Maute L, Wicht J and Bergmann
L: Curcumin inhibits constitutive STAT3 phosphorylation in human
pancreatic cancer cell lines and downregulation of survivin/BIRC5
gene expression. Cancer Invest. 28:166–171. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Anuchapreeda S, Tima S, Duangrat C and
Limtrakul P: Effect of pure curcumin, demethoxycurcumin and
bisdemethoxycurcumin on WT1 gene expression in leukemic cell lines.
Cancer Chemother Pharmacol. 62:585–594. 2008. View Article : Google Scholar
|
|
22
|
Gao W, Chan JY, Wei WI and Wong TS:
Anti-cancer effects of curcumin on head and neck cancers.
Anticancer Agents Med Chem. 12:1110–1116. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qiao Q, Jiang Y and Li G: Inhibition of
the PI3 K/AKT-NF-kappaB pathway with curcumin enhanced
radiation-induced apoptosis in human Burkitt's lymphoma. J
Pharmacol Sci. 121:247–256. 2013. View Article : Google Scholar
|
|
24
|
Termen S, Tan EJ, Heldin CH and Moustakas
A: p53 regulates epithelial-mesenchymal transition induced by
transforming growth factor β. J Cell Physiol. 228:801–813. 2013.
View Article : Google Scholar
|
|
25
|
Wang H, Zhang H, Tang L, Chen H, Wu C,
Zhao M, Yang Y, Chen X and Liu G: Resveratrol inhibits
TGF-β1-induced epithelial-to-mesenchymal transition and suppresses
lung cancer invasion and metastasis. Toxicology. 303:139–146. 2013.
View Article : Google Scholar
|
|
26
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: at the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang YL, Chen MW and Xian L: P rognostic
and clinicopathological significance of downregulated E-cadherin
expression in patients with non-small cell lung cancer (NSCLC): A
meta-analysis. PLoS One. 6:e997632014. View Article : Google Scholar
|
|
29
|
Liu D, Huang C, Kameyama K, Hayashi E,
Yamauchi A, Kobayashi S and Yokomise H: E-cadherin expression
associated with differentiation and prognosis in patients with
non-small cell lung cancer. Ann Thorac Surg. 71:949–954. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Al-Saad S, Al-Shibli K, Donnem T, Persson
M, Bremnes RM and Busund LT: The prognostic impact of NF-kappaB
p105, vimentin, E-cadherin and Par6 expression in epithelial and
stromal compartment in non-small-cell lung cancer. Br J Cancer.
99:1476–1483. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Satelli A and Li S: Vimentin in cancer and
its potential as a molecular target for cancer therapy. Cell Mol
Life Sci. 68:3033–3046. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kokkinos MI, Wafai R, Wong MK, Newgreen
DF, Thompson EW and Waltham M: Vimentin and epithelial-mesenchymal
transition in human breast cancer-observations in vitro and in
vivo. Cells Tissues Organs. 185:191–203. 2007. View Article : Google Scholar
|
|
33
|
Lv Q, Wang W, Xue J, Hua F, Mu R, Lin H,
Yan J, Lv X, Chen X and Hu ZW: DEDD interacts with PI3KC3 to
activate autophagy and attenuate epithelial-mesenchymal transition
in human breast cancer. Cancer Res. 72:3238–3250. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Macintosh RL, Timpson P, Thorburn J,
Anderson KI, Thorburn A and Ryan KM: Inhibition of autophagy
impairs tumor cell invasion in an organotypic model. Cell Cycle.
11:2022–2029. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang Z, Yang L, Xie L, Xu L, Xu D and Liu
X: Statins, autophagy and cancer metastasis. Int J Biochem Cell
Biol. 45:745–752. 2013. View Article : Google Scholar
|
